Pharmacovigilance  is about continuously monitoring the safety of a drug throughout its lifecycle, from clinical trials to its widespread use by the public. 

It's a legal, regulatory and ethical obligation that underpins public trust, ensures regulatory compliance, and protects a company's most valuable asset: its reputation.

National Drug Authority’s key expectations in regards to Pharmacovigilance in Uganda include:

• Mandatory adverse event reporting.
• Ongoing safety monitoring post-trial.
• Inspection ready PV systems that can be audited during NDA inspections.

Benefits of a Strong Pharmacovigilance System:

• Builds public trust.
• Ensures faster regulatory approvals.
• Protects company reputation.

Firms that integrate PV from day one of trials meet NDA compliance and build long-term value and meet compliance requirements. 

By proactively making patient safety a priority, pharmaceutical companies can foster public confidence, secure faster market approvals, and ultimately, thrive in the complex global pharmaceutical landscape.